Atypical antipsychotics are modestly useful in reducing aggression and psychosis in people with Alzheimer's disease, but their advantages are offset by serious adverse effects, such as stroke, movement difficulties or cognitive decline.
Atypiske antipsykotika er moderat anvendelige til at reducere aggression og psykose hos personer med Alzheimers sygdom, men deres nytte mindskes af deres alvorlige bivirkninger såsom slagtilfælde, bevægelsesvanskeligheder og kognitiv forringelse.